0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

The world’s organiser of patient intelligence by medicine

The smart way to understand patient experience

Cutting Edge Access to Patient Experience through AI.


Talking Medicines is a data tech company capturing, curating and structuring the global voice of the patient on launched medicines. Cutting edge data service PatientMetRx uses a combination of AI, ML and NLP to capture and analyse patient experience by medicine. Through mapping the patient voice to regulated medicine information, the company is able to build data points to deliver intelligence on usage across medicines driven by patient data. This intelligence meets compliance for the sector and enables marketing in big pharma to measure patient confidence in their medicines & action the levers for share growth.

Talk to us about

Our Team


Jo Halliday

Founder, CEO

Dr Elizabeth Fairley

Founder, COO

Dr Scott Crae MRCVS

Founder, Business Dev Director

Al Sisto


Ben Cons


Ross Hutcheson

Marketing Manager

Roma English Owen

Data Analyst

Vanja Popovic

Product Engineer

Gary Carson

Consultant Pharmacist

Rob Mackean

Finance Consultant

Julie Regamey

Project Manager

Ellie Halliday

Compliance and Legal

Stewart McKee

Full Stack Developer 

Olivia Lane

Sales & Marketing Intern 

Toby Corner


Tatiana Nantes

Head of Product

Tom Lynch

Senior Software Engineer

Adrian Mursec

Frontend Developer 

Soldo Moonshot Award


Applied AI 2.0 Award


What is PatientMetRx


How the pandemic is impacting the way drugs are launched

How the pandemic is impacting the way drugs are launched

Though we don’t yet know to what extent, it is clear the pandemic has had and will continue to have an impact on the pharmaceutical industry and how new drugs are launched. From a pharma perspective, not being able to communicate with healthcare professionals in their...

Softening of public attitude towards COVID-19 vaccines

Softening of public attitude towards COVID-19 vaccines

In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...

Proud to be affiliated with: